Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

STXS - Stereotaxis Inc


Close
2.29
0   0%

Share volume: 102,798
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$2.29
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
26%
Profitability 25%
Dept financing 20%
Liquidity 38%
Performance 25%
Company vs Stock growth
vs
Performance
5 Days
0   0%
1 Month
14.50%
3 Months
13.93%
6 Months
-18.51%
1 Year
34.71%
2 Year
10.63%
Key data
Stock price
$2.29
P/E Ratio 
-8.78
DAY RANGE
$2.22 - $2.31
EPS 
-$0.26
52 WEEK RANGE
$1.40 - $3.29
52 WEEK CHANGE
$0.26
MARKET CAP 
193.863 M
YIELD 
N/A
SHARES OUTSTANDING 
84.656 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
BETA 
0.63
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$223,078
AVERAGE 30 VOLUME 
$220,656
Company detail
CEO: David Fischel
Region: US
Website: http://www.stereotaxis.com/
Employees: 182
IPO year: -
Issue type: Common Stock
Market: NYSE American
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. these innovations help physicians provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. over 100 issued patents support the stereotaxis platform. the core components of stereotaxis’ systems have received regulatory clearance in the united states, european union, japan, canada, china, and elsewhere. for more information, please visit www.stereotaxis.com.

Recent news